Vericel (VCEL) Non-cash Items (2010 - 2014)
Vericel's (VCEL) quarterly Non-cash Items came in at $209375.0 in Q4 2014, up 43.4% year-on-year from $146003.0 in Q4 2013, and down 80.97% quarter-over-quarter from $1.1 million in Q3 2014.
Vericel (VCEL) Non-cash Items (2010 - 2014) Analysis & Trends
Vericel has disclosed Non-cash Items across 5 years of filings, most recently posting $209375.0 for Q4 2014.
- Non-cash Items for Q4 2014 came in at $209375.0, up 43.4% year-over-year; the trailing twelve-month figure through Dec 2014 was $209375.0 (up 43.4% YoY), and the FY2014 annual result was $209375.0, up 43.4% from the prior year.
- Non-cash Items came in at $209375.0 for Q4 2014 at Vericel, down from $1.1 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $5.1 million in Q4 2012 to a low of $2750.0 in Q2 2010.
- The 5-year median for Non-cash Items is $1.6 million (2013), against an average of $2.0 million.
- Across the five-year window, Non-cash Items soared 662.31% in 2012 and plunged 97.16% in 2013, its largest moves.
- Vericel's Non-cash Items stood at $3.2 million in 2010, then plunged by 78.66% to $674000.0 in 2011, then jumped by 662.31% to $5.1 million in 2012, then slumped by 97.16% to $146003.0 in 2013, then jumped by 43.4% to $209375.0 in 2014.
- The last three Non-cash Items figures came in at $209375.0 (Q4 2014), $1.1 million (Q3 2014), and $191888.0 (Q2 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 209,375.00 |
| Dec 31, 2014 | 209,375.00 |
| Sep 30, 2014 | 1.10 Mn |
| Sep 30, 2014 | 1.10 Mn |
| Jun 30, 2014 | 191,888.00 |
| Jun 30, 2014 | 191,888.00 |
| Mar 31, 2014 | 179,240.00 |
| Mar 31, 2014 | 179,240.00 |
| Dec 31, 2013 | 146,003.00 |
| Dec 31, 2013 | 146,003.00 |
| Sep 30, 2013 | 2.16 Mn |
| Sep 30, 2013 | 2.16 Mn |
| Jun 30, 2013 | 3.06 Mn |
| Jun 30, 2013 | 3.06 Mn |
| Mar 31, 2013 | 4.96 Mn |
| Mar 31, 2013 | 4.96 Mn |
| Dec 31, 2012 | 5.14 Mn |
| Dec 31, 2012 | 5.14 Mn |
| Sep 30, 2012 | 3.73 Mn |
| Sep 30, 2012 | 3.73 Mn |